Applied Finance Capital Management LLC Has $18.34 Million Stock Holdings in Danaher Co. (NYSE:DHR)

Applied Finance Capital Management LLC boosted its position in shares of Danaher Co. (NYSE:DHRFree Report) by 25.4% during the 4th quarter, Holdings Channel reports. The institutional investor owned 79,255 shares of the conglomerate’s stock after purchasing an additional 16,057 shares during the quarter. Applied Finance Capital Management LLC’s holdings in Danaher were worth $18,335,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of DHR. Allworth Financial LP lifted its stake in shares of Danaher by 7.9% in the 3rd quarter. Allworth Financial LP now owns 5,134 shares of the conglomerate’s stock valued at $1,274,000 after purchasing an additional 378 shares during the period. Wealthfront Advisers LLC boosted its stake in shares of Danaher by 20.2% during the 3rd quarter. Wealthfront Advisers LLC now owns 46,863 shares of the conglomerate’s stock worth $11,627,000 after buying an additional 7,873 shares during the last quarter. Trust Co of Kansas acquired a new position in shares of Danaher during the 3rd quarter worth about $244,000. Orion Portfolio Solutions LLC boosted its stake in shares of Danaher by 5.3% during the 3rd quarter. Orion Portfolio Solutions LLC now owns 93,854 shares of the conglomerate’s stock worth $23,285,000 after buying an additional 4,729 shares during the last quarter. Finally, New Mexico Educational Retirement Board boosted its stake in shares of Danaher by 8.5% during the 3rd quarter. New Mexico Educational Retirement Board now owns 34,535 shares of the conglomerate’s stock worth $8,568,000 after buying an additional 2,700 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently commented on DHR. Bank of America increased their price objective on shares of Danaher from $258.00 to $270.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 24th. KeyCorp raised their price objective on shares of Danaher from $260.00 to $290.00 and gave the stock an “overweight” rating in a research report on Thursday, February 1st. Robert W. Baird raised their price objective on shares of Danaher from $259.00 to $271.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 24th. HSBC upgraded shares of Danaher from a “hold” rating to a “buy” rating and raised their price objective for the stock from $250.00 to $280.00 in a research report on Wednesday, April 17th. Finally, Barclays raised their target price on shares of Danaher from $260.00 to $270.00 and gave the stock an “equal weight” rating in a report on Wednesday, April 24th. Six investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $267.31.

Get Our Latest Stock Analysis on Danaher

Danaher Price Performance

NYSE:DHR traded up $0.96 during mid-day trading on Friday, reaching $265.80. The stock had a trading volume of 3,187,418 shares, compared to its average volume of 2,621,433. The stock has a 50-day simple moving average of $248.74 and a two-hundred day simple moving average of $236.19. The stock has a market capitalization of $196.88 billion, a PE ratio of 45.05, a P/E/G ratio of 4.08 and a beta of 0.83. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.85 and a quick ratio of 1.51. Danaher Co. has a 12 month low of $182.09 and a 12 month high of $265.94.

Danaher (NYSE:DHRGet Free Report) last announced its quarterly earnings data on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.72 by $0.20. The business had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.62 billion. Danaher had a net margin of 16.78% and a return on equity of 11.43%. The firm’s quarterly revenue was down 2.6% compared to the same quarter last year. During the same period last year, the firm posted $2.36 earnings per share. On average, equities analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Stockholders of record on Friday, June 28th will be issued a dividend of $0.27 per share. The ex-dividend date of this dividend is Friday, June 28th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.41%. Danaher’s dividend payout ratio (DPR) is presently 18.31%.

Insider Transactions at Danaher

In other news, SVP Daniel Raskas sold 23,757 shares of Danaher stock in a transaction on Monday, February 26th. The shares were sold at an average price of $252.00, for a total transaction of $5,986,764.00. Following the transaction, the senior vice president now owns 38,102 shares in the company, valued at $9,601,704. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, CEO Rainer Blair sold 9,005 shares of the business’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $265.00, for a total value of $2,386,325.00. Following the transaction, the chief executive officer now owns 106,990 shares in the company, valued at $28,352,350. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, SVP Daniel Raskas sold 23,757 shares of the business’s stock in a transaction on Monday, February 26th. The shares were sold at an average price of $252.00, for a total transaction of $5,986,764.00. Following the completion of the transaction, the senior vice president now owns 38,102 shares in the company, valued at approximately $9,601,704. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 172,540 shares of company stock worth $43,523,481. Company insiders own 11.10% of the company’s stock.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.